These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17915423)

  • 21. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonsurgical treatment of thyroid tumours and its results.
    Scott JS
    Proc R Soc Med; 1974 Nov; 67(11):1106-7. PubMed ID: 4438292
    [No Abstract]   [Full Text] [Related]  

  • 23. Recombinant human TSH: the Argentinean experience.
    Pitoia F; Niepomniszcze H
    Thyroid; 2009 Jul; 19(7):799. PubMed ID: 19508122
    [No Abstract]   [Full Text] [Related]  

  • 24. [Role of diagnostic and therapeutic tools in the definition of differentiated thyroid carcinoma (1800-1950)].
    Fragu P
    Bull Cancer; 2000 Feb; 87(2):145-54. PubMed ID: 10705285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiated thyroid carcinoma in childhood.
    Dottorini ME
    Rays; 2000; 25(2):245-55. PubMed ID: 11370542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The biological classifications of malignant thyroid tumours (author's transl)].
    Kokoschka R; Roka R; Depisch D; Aiginger P; Weissel M; Kolbe H; Krisch K
    Wien Klin Wochenschr; 1979 Sep; 91(18):605-10. PubMed ID: 483824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid cancer in infants and adolescents after Chernobyl.
    Reiners C; Demidchik YE; Drozd VM; Biko J
    Minerva Endocrinol; 2008 Dec; 33(4):381-95. PubMed ID: 18923372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolated thyrotropin deficiency secondary to primary empty sella in a patient with differentiated thyroid carcinoma: an indication for recombinant thyrotropin.
    Colleran KM; Burge MR
    Thyroid; 1999 Dec; 9(12):1249-52. PubMed ID: 10646666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Endocrinology].
    Meyer P
    Rev Med Suisse; 2008 Jan; 4(139):14-7. PubMed ID: 18251209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the effectiveness of recombinant human TSH as a stimulating agent for 131I treatment of metastatic differentiated thyroid cancer.
    Zanotti-Fregonara P; Hindié E
    Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2264-6. PubMed ID: 20821206
    [No Abstract]   [Full Text] [Related]  

  • 31. Radioiodine in the treatment of thyroid cancer.
    Van Nostrand D; Wartofsky L
    Endocrinol Metab Clin North Am; 2007 Sep; 36(3):807-22, vii-viii. PubMed ID: 17673129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged follow-up of multinodular goitre patients treated with radioiodine preceded or not by human recombinant TSH.
    Cardia MS; Rubio IG; Medeiros-Neto G
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):474. PubMed ID: 16584523
    [No Abstract]   [Full Text] [Related]  

  • 33. Radioiodine treatment for benign thyroid diseases.
    Weetman AP
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):757-64. PubMed ID: 17466000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology of bovine and human thyrotropin: an historical perspective.
    Robbins J
    Thyroid; 1999 May; 9(5):451-3. PubMed ID: 10365676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of thyroid carcinoma using radioiodine].
    Santora J; Nĕmec J; Kubinyi J
    Cas Lek Cesk; 2001 Apr; 140(7):217-9. PubMed ID: 11374227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastatic differentiated thyroid carcinoma: clinical management and outcome of disease in patients with initial and late distant metastases.
    Mihailovic JM; Stefanovic LJ; Malesevic MD; Erak MD; Tesanovic DD
    Nucl Med Commun; 2009 Jul; 30(7):558-64. PubMed ID: 19436230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Commentary on article by Rudavsky and Freeman.
    Lukinac L; Franceschi D; Kusic Z
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4277. PubMed ID: 9398757
    [No Abstract]   [Full Text] [Related]  

  • 38. [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)].
    Dietlein M; Dressler J; Eschner W; Grünwald F; Lassmann M; Leisner B; Luster M; Moser E; Reiners C; Schicha H; Schober O; ;
    Nuklearmedizin; 2007; 46(5):213-9. PubMed ID: 17938757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioiodine treatment of well-differentiated thyroid cancer.
    Wartofsky L; Van Nostrand D
    Endocrine; 2012 Dec; 42(3):506-13. PubMed ID: 22733393
    [No Abstract]   [Full Text] [Related]  

  • 40. Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation.
    Grewal RK; Larson SM; Pentlow CE; Pentlow KS; Gonen M; Qualey R; Natbony L; Tuttle RM
    J Nucl Med; 2009 Oct; 50(10):1605-10. PubMed ID: 19759114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.